Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2Head & Neck 1Gastrointestinal 1

Conditions

Lung Neoplasms 2Sarcoidosis 1Lung Diseases, Interstitial 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Conscious Sedation × Thoracic × Clear all
NCT02245295 2016-11-15

The Role of Sedation Technique in EBUS-TBNA

University of Zurich

Completed
232 enrolled
Thoracic

Lung Neoplasms

NCT02246023 2016-04-14

Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy

University of Zurich

Phase 4 Completed
78 enrolled
Thoracic

Lung Neoplasms, Sarcoidosis, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡